Agilent acquires Stratagene
Agilent Technologies has announced the acquisition of the company Stratagene, effective as of today.
The takeover is hoped to assist the company in providing more complete workflow solutions in genomics, proteomics and metabolomics.
Stratagene will operate as a division of the company's Life Sciences Solutions unit.
The company has said current customers should expect no change in the way they work with Stratagene and should be able to continue using their existing contact channels.
New Albanese ministry urged to advance Aust innovation
Organisations including Cooperative Research Australia, ATSE and the Australian Academy of...
Govt and industry fund health and biotech innovation in SEQ
The SEQ Innovation Economy Fund has awarded eight projects $94m in government funding, while...
Does the 2025–26 Budget do enough for science?
AAMRI has described the 2025–26 federal Budget as "very disappointing" for the...
